Pheochromocytoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
*[[stress]] | *[[stress]] | ||
*[[Exercise]] | *[[Exercise]] | ||
*[[Medication]]s such as | *[[Medication]]s such as [[stimulant]]s, [[methyldopa]], [[dopamine]] [[agonist]]s | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 14:22, 2 September 2015
Pheochromocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pheochromocytoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Pheochromocytoma differential diagnosis |
Risk calculators and risk factors for Pheochromocytoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Differentiating Pheochromocytoma from other Diseases
The differential diagnosis of pheochromocytoma includes:
- Anxiety disorders
- Carcinoid tumor
- Paragangliomas
- Essential hypertension
- Hyperthyroidism
- Insulinoma
- Paroxysmal supraventricular tachycardia
- Renovascular hypertension
- Hypoglycemia
- stress
- Exercise
- Medications such as stimulants, methyldopa, dopamine agonists